CN110755884B - Method for extracting biological product by reverse adsorption - Google Patents

Method for extracting biological product by reverse adsorption Download PDF

Info

Publication number
CN110755884B
CN110755884B CN201911111377.3A CN201911111377A CN110755884B CN 110755884 B CN110755884 B CN 110755884B CN 201911111377 A CN201911111377 A CN 201911111377A CN 110755884 B CN110755884 B CN 110755884B
Authority
CN
China
Prior art keywords
column
liquid
resin
adsorption
biological product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911111377.3A
Other languages
Chinese (zh)
Other versions
CN110755884A (en
Inventor
彭继先
于海勤
刘艳平
黄明华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Ruizhi Pharmaceutical Technology Co ltd
Original Assignee
Shandong Ruizhi Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Ruizhi Pharmaceutical Technology Co ltd filed Critical Shandong Ruizhi Pharmaceutical Technology Co ltd
Priority to CN201911111377.3A priority Critical patent/CN110755884B/en
Publication of CN110755884A publication Critical patent/CN110755884A/en
Application granted granted Critical
Publication of CN110755884B publication Critical patent/CN110755884B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1807Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using counter-currents, e.g. fluidised beds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/16Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
    • B01D15/166Fluid composition conditioning, e.g. gradient
    • B01D15/168Fluid composition conditioning, e.g. gradient pH gradient, chromatofocusing, i.e. separation according to the isoelectric point pI
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a method for extracting biological products by reverse adsorption. The invention utilizes macroporous adsorption resin to directly extract weak polar or non-polar products from biological product liquid containing cells and mycelium fragments in a reverse column adsorption mode, and the extracted products have high purity. The method not only overcomes a series of defects caused by using organic solvent for extraction in the traditional biological product extraction, but also solves the contradiction that the column feeding liquid is strictly required in the traditional resin separation. The invention has simple technical process, strong selective adsorption to products, good product quality and less production waste; meanwhile, the invention can help realize the on-line extraction and continuous production of partial biological products.

Description

Method for extracting biological product by reverse adsorption
Technical Field
The invention relates to the technical field of biochemistry, in particular to a method for reversely adsorbing and extracting a biological product.
Background
Biotransformation and enzyme catalysis are two important methods for producing drugs and drug intermediates, and because the methods have the characteristics of low pollution and high stereoselectivity, chemical synthesis methods of many products are gradually replaced at present. Although the immobilized cell and immobilized enzyme technology in the prior art is applied to the production of certain biological products, and certain liquid enzymes are also used in the form of clear liquid, most of the biocatalysts participate in biological reactions in the form of whole cells or whole cell disruption liquid due to the instability of the biocatalysts, so that the product is difficult to extract from the reaction system after the reaction is finished. Most products produced by the biotransformation and enzyme catalysis methods have large molecular weight, low polarity and small water solubility, so the extraction by using an organic solvent becomes a commonly used and most classical method in the extraction process of biological products. However, the organic solvent extraction generates emulsification, water-soluble impurities generated in the emulsification affect the product quality, and a part of organic solvent remaining in the extraction mother liquor can cause heavy pressure on a sewage treatment system.
Resin separation methods are also used for bioproduct extraction, but traditionally the column fluid must be a clear fluid or the column of resin can become clogged. In production, solid substances such as mycelium and the like in biological product liquid are generally removed by adopting a filtering method, but a flocculating agent is added for pretreatment; since the optimum PH range for use of flocculants is generally from neutral to slightly acidic, this method is not suitable when the biological product liquid contains solid products, and the large amount of filter cake produced by filtration inevitably entrains a portion of the product, which also has a certain effect on the product yield.
At present, the resin separation method generally adopted in the experimental process is that the resin column feeding mode is generally positive column feeding, namely, the column feeding liquid enters from the upper part of the resin column and flows out from the bottom. The forward column loading has the advantages of clear chromatographic distribution of the product on the resin column, high exchange saturation, good product quality, long exchange period and high requirement on column loading liquid quality. The upper column liquid enters from the bottom of the resin column and is discharged from the upper part of the resin column, which is called as a reverse upper column, and the reverse upper column is generally considered to have the defects of unobvious chromatographic distribution and low adsorption quantity, so that no report of the current practical application is found in the reverse upper column method in production or scientific research.
Disclosure of Invention
In order to make up for the deficiencies of the prior art, the present invention provides a method for reverse adsorption extraction of a biological product.
The technical scheme adopted by the invention is as follows:
a method for reverse adsorption extraction of a biological product comprising the steps of:
step 1): filtering the biological product liquid through a 60-120 mesh filter screen, and adjusting the pH value;
step 2), arranging 40-60 mesh filter screens at the upper end and the lower end in the resin column to prevent the resin filler from losing;
step 3): adsorbing on the column in a reverse column loading mode, wherein the flow rate of the column loading is 3-5 BV/h; collecting column passing liquid, and treating the column passing liquid in a sewage treatment plant;
step 4): when the resin adsorption amount reaches 60-70% of the saturated adsorption amount, switching, and performing back flushing by using deionized water, wherein the flushing rate is 3-6BV/h, and the flushing time is 0.5-2 h;
step 5): desorbing at a desorption rate of 0.5-2 BV/h; collecting the desorption solution, and extracting the product.
Preferably, the biological product in step 1) is a medium polar substance, a low polar substance or a non-polar substance.
Preferably, the liquid source of the biological product in the step 1) is a biological conversion liquid, an enzyme catalysis reaction liquid or a biological fermentation liquid.
Preferably, the biological product liquid in step 1) is an aqueous phase and does not contain an organic solvent.
Preferably, the filler used in step 2) is macroporous adsorption resin, and the macroporous adsorption resin is medium-polarity macroporous adsorption resin, weak-polarity macroporous adsorption resin or non-polarity macroporous adsorption resin.
Preferably, the stem height ratio of the resin column in step 2) is 1: 8-14.
Preferably, the resin column in step 2) is used in the form of a single column or multiple columns in series.
Preferably, the indication of the end of rinsing in step 4): the rinsing effluent was clear and transparent.
Preferably, the desorption manner in step 5) comprises forward desorption or reverse desorption.
Compared with the prior art, the invention has the beneficial effects that:
the particle size range of the resin is generally 300-1000 microns, the size of cells or broken mycelia in the biological product liquid is micron and submicron, and the higher column feeding rate and washing rate in the application enable the resin particles to be in a semi-suspension state, so that the problem of resin column blockage in the adsorption process of the application can not be caused. The internal pore diameter of the macroporous adsorption resin is generally from several nanometers to dozens of nanometers, and only substances with molecular level sizes can enter the resin, so that suspended solid substances in the liquid of the biological product cannot influence the adsorption of the resin on the product. The larger stem height ratio of the resin column or the serial connection of the resin columns are used, so that the liquid of the biological product to be extracted is fully absorbed, and the absorption effect and the product recovery rate of the product are improved.
The invention successfully completes the separation of two mechanism directions by using a reverse adsorption method: substances with the particle size of more than 100 nanometers, including almost all cells and mycelium fragments, can not enter the resin particles to be adsorbed, flow through gaps of the resin particles and are discharged along with column passing liquid; the medium molecular weight and small molecular weight substances entering the resin particles almost have higher polarity and hydrophilicity except the product and are not adsorbed, and finally flow out along with column passing liquid and washing water, so that the high-efficiency adsorption separation of the product to be extracted is completed.
Many biological products are weakly acidic or weakly basic substances, and their solubility and polarity change with the change of pH. The invention controls the polarity of the extracted product to be at an ideal level by adjusting the PH of the biological product liquid, and then completes the accurate adsorption and separation of the product by selecting the adsorption resin with the proper polarity level for adsorption. It has been proved by sufficient experimental data that almost all biological products extracted by organic solvents can be separated and extracted by adsorption resins.
The invention carries out reverse adsorption extraction on the non-high-polarity biological product through the macroporous adsorption resin, and the regeneration of the resin is finished by flushing with deionized water after desorption, so that the production waste is reduced to the minimum degree.
The invention directly absorbs and extracts the biological product liquid containing the cell or mycelium fragments by a reverse column loading mode, thereby not only simplifying the production process, but also obtaining a high-purity product; in addition, the reverse adsorption technology provided by the invention is expected to realize on-line extraction, continuous extraction and continuous production of certain products.
Detailed Description
The first embodiment is as follows:
preparation of a bioconversion liquid: culturing colletotrichum in 30L fermentation medium for 18h, adding sterile processed solid dehydroepiandrosterone (prasterone) 80g, ventilating at 29 deg.C under 1.8 Nm/h, performing bioconversion for about 30h, detecting by TLC, and finishing culturing after conversion to obtain bioconversion solution. Detecting the biotransformation liquid by HPLC, wherein dehydroepiandrosterone is not detected, 7-hydroxydehydroepiandrosterone is not detected, and dihydroxyprasterone (7 alpha, 15 alpha-dihydroxyandrostenol ketone) is 2.21 mg/ml; and (3) adding 60L of deionized water into the biotransformation liquid for dilution, then carrying out primary crushing by using a colloid mill, and then carrying out secondary crushing by using a high-pressure homogenizer, wherein the homogenization pressure is 60MP, so that the dihydroxyprasterone product is fully released from the mycelium, and the biological product liquid to be detected is obtained.
The method for extracting the biological product through reverse adsorption comprises the following steps:
step 1): carrying out HPLC detection on 4800ml of the biological product liquid to be detected, wherein the detection result is that the content of the dihydroxyprasterone is 0.73 mg/ml; filtering the biological product liquid to be detected by a 120-mesh filter screen, detecting the PH of the filtrate to be 6.64, and adjusting the PH to be 7.2 by using liquid alkali;
step 2): adopting a resin column with the specification of theta 22 multiplied by 400, fixing a 60-mesh stainless steel filter screen at the bottom in the resin column, filling 80ml of nonpolar macroporous adsorption resin above the stainless steel filter screen, reserving a space with the height of 50mm at the upper part of the nonpolar macroporous adsorption resin, and then fixing another 60-mesh stainless steel filter screen; in the step, the upper opening of the resin column is sealed by a rubber plug with a liquid discharge rubber tube, and a latex tube with the length of about 1m is arranged at the lower opening of the resin column to be used as an upper column liquid inlet;
step 3): performing reverse column-loading adsorption on the biological product liquid subjected to filtration treatment in the step 1) by using the resin column treated in the step 2), wherein the column-loading flow rate is 300 ml/h; collecting the column-passing liquid, and pumping the column-passing liquid into a sewage treatment plant for treatment;
step 4): the adsorption capacity of the resin reaches 60-70% of the saturated adsorption capacity, and the column loading is finished; reversely washing with deionized water at a washing rate of 400ml/h, clarifying the washing effluent after washing for 0.5h, and finishing washing;
step 5): carrying out forward desorption by using acetone at the flow rate of 80ml/h, discarding 40ml of the initial desorption solution, collecting 340ml of the desorption solution, and forward washing and regenerating the resin column by using 200ml of deionized water; recovering acetone from the desorption solution, stopping distillation when the concentration volume is reduced to about 20ml, cooling to 4-8 ℃ for crystallization, filtering and drying to obtain a product 3.15g, wherein the content of the dihydroxyprasterone is 98.7%.
Example two:
preparation of a bioconversion liquid: the same procedure was followed as in the first example to prepare the biotransformation liquid.
The method for extracting the biological product through reverse adsorption comprises the following steps:
step 1): 4000ml of the biological product liquid to be detected prepared in the second embodiment is taken, filtered by a 100-mesh filter screen, and the PH value is adjusted to 7.15 by liquid alkali;
step 2), adopting a resin column with the specification of theta 22 multiplied by 400, fixing a 40-mesh stainless steel filter screen at the bottom in the resin column, then filling 70ml of nonpolar macroporous adsorption resin above the stainless steel filter screen, reserving a space with the height of 60mm at the upper part of the nonpolar macroporous adsorption resin, and then fixing another 40-mesh stainless steel filter screen; in the step, the two same resin columns are connected in series by a rubber plug and a rubber tube, the upper opening of the upper resin column is sealed by the rubber plug with a liquid discharge rubber tube, and the lower opening of the lower resin column is provided with an emulsion tube with the length of about 1.5m as an upper column liquid inlet;
step 3): performing reverse column-loading adsorption on the biological product liquid subjected to filtration treatment in the step 1) by using the resin column treated in the step 2), wherein the column-loading flow rate is 350 ml/h; collecting the column-passing liquid, and treating the filtrate in a sewage treatment plant;
step 4): the adsorption capacity of the resin reaches 60-70% of the saturated adsorption capacity, and the column loading is finished; separating two resin columns connected in series, wherein the upper resin column is directly used for the next batch of first-stage loading columns, the lower resin column is reversely flushed with deionized water at the flow rate of 400ml/h, the effluent is clarified after flushing for 0.5h, and the flushing is finished;
step 5): carrying out forward desorption by using acetone at the flow rate of 70ml/h, discarding 35ml of desorption solution, collecting 300ml of desorption solution, and forward washing and regenerating the resin column by using 200ml of deionized water; recovering acetone from the desorption solution, evaporating to obtain a solid, collecting the solid, stirring and washing with 60ml of 4 ℃ n-heptane, filtering, and drying to obtain 2.78g of the product with the content of the dihydroxyl prasterone of 99.3%.
Example three:
preparation of a bioconversion liquid: recombining 7-beta dehydrogenase composite glucose dehydrogenase gene into engineering escherichia coli, culturing, and centrifugally collecting thalli; taking 100g of thalli in parts by weight, suspending the thalli in 400g of deionized water, carrying out ultrasonic crushing to obtain a whole-thallus enzyme solution, adding 25g of glucose, adding 10g of 7-ketolithocholic acid, and carrying out catalytic reaction for 8 hours to obtain 627ml of ursodeoxycholic acid reaction solution, wherein the content of the ursodeoxycholic acid is 15.15 mg/ml;
the method for extracting the biological product through reverse adsorption comprises the following steps:
step 1): taking 300ml of ursodeoxycholic acid reaction solution, adding 300ml of deionized water, adjusting the pH value to 9.0 by using liquid alkali, and filtering by using a 80-mesh filter screen;
step 2), adopting a resin column with the specification of theta 22 multiplied by 400, fixing a 40-mesh stainless steel filter screen at the bottom in the resin column, then filling 80ml of medium-polarity macroporous adsorption resin above the stainless steel filter screen, reserving a space with the height of 60mm at the upper part of the medium-polarity macroporous adsorption resin, and then fixing another 40-mesh stainless steel filter screen; in the step, the upper opening of the resin column is sealed by a rubber plug with a liquid discharge rubber tube, and the lower opening of the resin column is provided with a latex tube with the length of about 1m as an upper column liquid inlet;
step 3): carrying out reverse column-loading adsorption on the ursodeoxycholic acid reaction solution subjected to filtering treatment in the step 1) by using the resin column treated in the step 2), wherein the column-loading flow rate is 300 ml/h; collecting the column-passing liquid, and treating the filtrate in a sewage treatment plant;
step 4): the adsorption capacity of the resin reaches 60-70% of the saturated adsorption capacity, and the column loading is finished; reversely washing with deionized water at a washing rate of 400ml/h, clarifying the washing effluent after washing for 0.5h, and finishing washing;
step 5): reversely desorbing with 50% ethanol solution at flow rate of 60ml/h, collecting 300ml of all desorption solution, and positively washing and regenerating the resin column with 200ml of deionized water; recovering ethanol from the desorption solution, concentrating to 180ml, adjusting pH to 2.5 with sulfuric acid, crystallizing for 4h, filtering, and drying to obtain ursodeoxycholic acid product 4.43g with ursodeoxycholic acid content of 98.9%.
The above-described embodiment is only one of the preferred embodiments of the present invention, and general changes and substitutions by those skilled in the art within the technical scope of the present invention are included in the protection scope of the present invention.

Claims (1)

1. A method for reverse adsorption extraction of biological products, comprising: preparation of the biotransformation liquid: culturing colletotrichum in 30L fermentation medium for 18h, adding sterile-processed solid dehydroepiandrosterone 80g, ventilating at 29 deg.C under a flow rate of 1.8 Nm/h, performing biotransformation for about 30h, detecting by TLC, and finishing culturing after the transformation to obtain biotransformation liquid;
detecting the biotransformation liquid by HPLC, wherein dehydroepiandrosterone is not detected, 7-hydroxydehydroepiandrosterone is not detected, and dihydroxyprasterone is 2.21 mg/ml; diluting the biotransformation liquid with 60L of deionized water, performing primary crushing by using a colloid mill, and performing secondary crushing by using a high-pressure homogenizer, wherein the homogenization pressure is 60MP, so that the dihydroxyprasterone product is fully released from the mycelium, and thus obtaining the liquid of the biological product to be detected;
a method for reverse adsorption extraction of a biological product comprising the steps of:
step 1): 4000ml of biological product liquid to be detected is taken, filtered by a 100-mesh filter screen, and the PH value is adjusted to 7.15 by liquid alkali;
step 2): adopting a resin column with the specification of theta 22 multiplied by 400, fixing a 40-mesh stainless steel filter screen at the bottom in the resin column, then filling 70ml of nonpolar macroporous adsorption resin above the stainless steel filter screen, reserving a space with the height of 60mm at the upper part of the nonpolar macroporous adsorption resin, and then fixing another 40-mesh stainless steel filter screen; in the step, the two same resin columns are connected in series by a rubber plug and a rubber tube, the upper opening of the upper resin column is sealed by the rubber plug with a liquid discharge rubber tube, and the lower opening of the lower resin column is provided with an emulsion tube with the length of about 1.5m as an upper column liquid inlet;
step 3): performing reverse column-loading adsorption on the biological product liquid subjected to filtration treatment in the step 1) by using the resin column treated in the step 2), wherein the column-loading flow rate is 350 ml/h; collecting the column-passing liquid, and treating the filtrate in a sewage treatment plant;
step 4): the adsorption capacity of the resin reaches 60-70% of the saturated adsorption capacity, and the column loading is finished; separating two resin columns connected in series, wherein the upper resin column is directly used for the next batch of first-stage loading columns, the lower resin column is reversely flushed with deionized water at the flow rate of 400ml/h, the effluent is clarified after flushing for 0.5h, and the flushing is finished;
step 5): carrying out forward desorption by using acetone at the flow rate of 70ml/h, discarding 35ml of desorption solution, collecting 300ml of desorption solution, and forward washing and regenerating the resin column by using 200ml of deionized water; recovering acetone from the desorption solution, evaporating to obtain a solid, collecting the solid, stirring and washing with 60ml of 4 ℃ n-heptane, filtering, and drying to obtain 2.78g of the product with the content of the dihydroxyl prasterone of 99.3%.
CN201911111377.3A 2019-11-14 2019-11-14 Method for extracting biological product by reverse adsorption Active CN110755884B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911111377.3A CN110755884B (en) 2019-11-14 2019-11-14 Method for extracting biological product by reverse adsorption

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911111377.3A CN110755884B (en) 2019-11-14 2019-11-14 Method for extracting biological product by reverse adsorption

Publications (2)

Publication Number Publication Date
CN110755884A CN110755884A (en) 2020-02-07
CN110755884B true CN110755884B (en) 2022-01-18

Family

ID=69338157

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911111377.3A Active CN110755884B (en) 2019-11-14 2019-11-14 Method for extracting biological product by reverse adsorption

Country Status (1)

Country Link
CN (1) CN110755884B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134067A (en) * 2021-10-19 2022-03-04 山东睿智医药科技有限公司 Escherichia coli and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008240078A1 (en) * 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Multi-dimensional chromatographic methods for separating N-glycans
CN204261380U (en) * 2014-11-26 2015-04-15 四川九章生物科技有限公司 A kind of adsorption separation device of purifying chlorogenic acid
CN105324165A (en) * 2013-03-08 2016-02-10 希乐克公司 Processing biomass material
CN105884736A (en) * 2016-04-19 2016-08-24 中国科学院西北高原生物研究所 Method for separating and preparing 5 flavonoid compounds from Oxytropis falcate Bunge
CN108929302A (en) * 2017-05-27 2018-12-04 浙江大学 Separation method and a kind of porous poly ion liquid material of a kind of mixed tocopherol and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7988859B2 (en) * 2009-02-05 2011-08-02 Chromatan Inc. Countercurrent tangential chromatography methods, systems, and apparatus
US9679757B2 (en) * 2013-04-12 2017-06-13 Waters Technologies Corporation Liquid chromatography systems and methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008240078A1 (en) * 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Multi-dimensional chromatographic methods for separating N-glycans
CN105324165A (en) * 2013-03-08 2016-02-10 希乐克公司 Processing biomass material
CN204261380U (en) * 2014-11-26 2015-04-15 四川九章生物科技有限公司 A kind of adsorption separation device of purifying chlorogenic acid
CN105884736A (en) * 2016-04-19 2016-08-24 中国科学院西北高原生物研究所 Method for separating and preparing 5 flavonoid compounds from Oxytropis falcate Bunge
CN108929302A (en) * 2017-05-27 2018-12-04 浙江大学 Separation method and a kind of porous poly ion liquid material of a kind of mixed tocopherol and preparation method thereof

Also Published As

Publication number Publication date
CN110755884A (en) 2020-02-07

Similar Documents

Publication Publication Date Title
CN106755143B (en) Method for continuously extracting high-purity lactic acid from lactic acid fermentation liquor
JPS6329999B2 (en)
CN110755884B (en) Method for extracting biological product by reverse adsorption
CN102267919A (en) Preparation method of L-dopa from Mucuna pruriens
EP0908523B1 (en) Process for producing high-purity erythritol crystal
CN105154499B (en) The preparation method of L-aspartic acid-L-ornithine
CN105198732A (en) Method for extracting alpha-ketoglutaric acid from fermentation liquor
CN112321408A (en) Equipment and method for extracting vitamin K2 from microbial fermentation liquor
CN1266158C (en) Method for separating and extracting D-ribose from fermented liquid by film separating technology
CN109929896A (en) A kind of production technology of ursodesoxycholic acid
CN106861236B (en) A method of utilizing hypercrosslinked polymeric resin adsorbing separation pentanediamine
CN108004276A (en) The structure and circular flow method of a kind of ketone group reduction catalysts system
CN107417749A (en) A kind of resin extender separation method of DPN
CN110804078A (en) Deep decolorization and purification method of glycerol glucoside
CN107573396B (en) Method for purifying and preparing high-purity chenodeoxycholic acid by utilizing chromatography-3 and dynamic axial compression column chromatography
CN109553650B (en) Water phase extraction method of erythromycin fermentation liquor
EP0135728B1 (en) Isolation of enzymetically prepared carboxylic acids
CN110396058A (en) A kind of novel calcifediol (25-hydroxyvitamin D3) isolation and purification method
CN106554273B (en) Method for purifying long-chain dicarboxylic acid in fermentation liquor
CN109836468A (en) A method of the purifying citicoline sodium from microbial fermentation solution
CN104152508A (en) Method for direct extraction of genipin from waste liquid in gardenia yellow pigment production
CN112480127A (en) Novel method for producing mitomycin
CN106220646A (en) A kind of method that recycling of enzymatic clarification cefalexin mother solution
CN111065644B (en) Method for preparing high-purity NAD
CN106282289B (en) Preparation method of androstane-1, 4-diene-3, 17-diketone and fermentation medium used by same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant